$19.120
-0.572 (-2.99%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ACAD Prediction & Forecast by Similar Chart Analysis
Alphio's ACAD stock price prediction model matches the current Acadia Pharmaceuticals Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.10 (-0.11%). The 1-week path is $19.32 (+1.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Acadia Pharmaceuticals Inc. Stock?
Given the current price of $19.12 and an RSI of 34.575, ACADIA Pharmaceuticals is not a strong buy at this moment. The stock has seen a significant decline of 29.94% over the past 20 days, indicating bearish momentum. While the gross margin remains high at 90.81%, the recent clinical trial setbacks and lowered analyst price targets suggest caution. The main risk is the potential for further declines if the company fails to regain investor confidence, especially as the stock is already down 27.27% year-to-date.
ACAD stock price ended at $19.12 on Friday, after losing -2.99%
Acadia Pharmaceuticals Inc. (ACAD) last closed at $19.12, losing -2.99%. These facts feed the 1-day and 1-week ACAD price prediction above.
Analyst Consensus
Acadia Pharmaceuticals Inc. (ACAD): 8 buy, 2 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Acadia Pharmaceuticals Inc. (ACAD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ACAD, ranked by similarity.
Seasonality analysis for ACAD
Historically the probability of a positive October return for ACAD is 39.66%. August offers the highest probability of a positive month at 64.06%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ACAD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $21.38 | $22.99 | $25.36 | +20.24% |
| Nov 2026 | $22.81 | $28.51 | $30.75 | +49.12% |
| Dec 2026 | $19.57 | $21.36 | $26.83 | +11.72% |
In 2026, Acadia Pharmaceuticals Inc. (ACAD) is projected to range from $19.57 to $30.75.
Acadia Pharmaceuticals Inc. 2026 monthly forecast
In Oct 2026, Acadia Pharmaceuticals Inc. is projected to average $22.99, with a low of $21.38 and high of $25.36.
In Nov 2026, Acadia Pharmaceuticals Inc. is projected to average $28.51, with a low of $22.81 and high of $30.75.
In Dec 2026, Acadia Pharmaceuticals Inc. is projected to average $21.36, with a low of $19.57 and high of $26.83.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.